Schering-Plough Corporation's Hepatitis C Drug Works About The Same As Roche's, Johns Hopkins University Study
CHICAGO (Reuters) - Two standard treatments for hepatitis C work equally well at knocking down the virus for most patients, U.S. researchers reported on Wednesday.